References
  1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol . 2009;104(11):1534-1539.
  2. Borzecki AM, Bridgers DK, Liebschutz JM, Kader B, Kazis SLE, Berlowitz DR. Racial differences in the prevalence of atrial fibrillation among males. J Nat Med Assoc . 2008;100(2):237-246.
  3. Hernandez MB, Asher CR, Hernandez AV, Novaro GM. African american race and prevalence of atrial fibrillation: A meta-analysis. Cardiol Res Pract . 2012;2012:1-7.
  4. Marcus GM, Alonso A, Peralta CA, et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation . 2010;122(20):2009-2015.
  5. Linares JD, Jackson LR, Dawood FZ, et al. Prevalence of atrial fibrillation and association with clinical, sociocultural, and ancestral correlates among Hispanic/Latinos: The Hispanic Community Health Study/Study of Latinos. Heart Rhythm . 2019;16(5):686-693.
  6. Bush D, Martin LW, Leman R, Chandler M, Haywood LJ, NHLBI AFFIRM Investigators. Atrial fibrillation among African Americans, Hispanics and Caucasians: Clinical features and outcomes from the AFFIRM Trial. J Natl Med Assoc . 2006;98(3):330-339.
  7. Soliman EZ, Prineas RJ, Go AS, et al. Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC). Am Heart J . 2010;159(6):1102-1107.
  8. Genovesi S, Pogliani D, Faini A, et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kid Dis . 2005;46(5):897-902.
  9. Vázquez E, Sánchez-Perales C, Borrego F, et al. Influence of atrial fibrillation on the morbid-mortality of patients on hemodialysis. Am Heart J . 2000;140(6):886-890.
  10. Fabbian F, Catalano C, Lambertini D, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol . 2000;54(3):234-239.
  11. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Renal Failure . 2001;23(1):71-76.
  12. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kid Intern . 1998;54(5):1720-1725..
  13. Wang TJ, Parise H, Levy D. Obesity and the risk of new-onset atrial fibrillation. JAMA . 2004;292(20):2471-2477.
  14. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study. Am Heart J. 2009;158(4):629-636.
  15. Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998;53(5):1343-1347.
  16. Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter. Am J Kid Dis . 2001;38(6):1398-1407.
  17. Chen J, Muntner P, Hamm LL, et al. The Metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med . 2004;140:167-174.
  18. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of Atrial Fibrillation on the Risk of Death. Circulation . 1998;98(10):946-952.
  19. Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality Trends in Patients Diagnosed With First Atrial Fibrillation. J Am Coll Cardiol . 2007;49(9):986-992.
  20. Soliman EZ, Safford MM, Muntner P, et al. Atrial Fibrillation and the Risk of Myocardial Infarction. JAMA Intern Med . 2014;174(1):107.
  21. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: A systematic review. Neurology . 2007;69(6):546-554.
  22. Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Circulation . 2013;127(2):224-232.
  23. Lee M, Saver JL, Chang K-H, Liao H-W, Chang S-C, Ovbiagele B. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ . 2010;341(sep30 1):c4249-c4249. doi:10.1136/bmj.c4249.
  24. Masson P, Webster AC, Hong M, Turner R, Lindley RI, Craig JC. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrology Dialysis Transplantation . 2015;30(7):1162-1169.
  25. Angelantonio ED, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ . 2010;341(sep30 1):c4986-c4986. doi:10.1136/bmj.c4986.
  26. Meisinger C, Döring A, Löwel H. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J. 2006;27(10):1245-1250.
  27. Tonelli M, Wiebe N, Culleton B, et al. Chronic Kidney Disease and Mortality Risk: A Systematic Review. J Am Soc Nephrol . 2006;17(7):2034-2047.
  28. Research, Statistics, Data & Systems. CMS. https://www.cms.gov/Research-Statistics-Data-and-Systems/Research-Statistics-Data-and-Systems. Accessed May 20, 2020.
  29. Chalazan B, Mol D, Sridhar A, et al. Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort. PloS One . 2018;13(4). doi:10.1371/journal.pone.0194480.
  30. Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation. Circulation . 2009;119(10):1363-1369.
  31. Nakayama M, Metoki H, Terawaki H, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population–the Ohasama study. Nephrology Dialysis Transplantation . 2007;22(7):1910-1915.
  32. Vazquez E, Sanchez-Perales C, Garcia-Garcia F, et al. Atrial fibrillation in incident dialysis patients. Kidney Int . 2009;76(3):324-330.L
  33. U.S. Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006
  34. Bos MJ, Koudstaal PJ, Hofman A, Breteler MM. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke. Stroke . 2007;38(12):3127-3132.
  35. Nakagawa K, Hirai T, Takashima S, et al. Chronic Kidney Disease and CHADS2 score independently predict cardiovascular events and mortality in patients With nonvalvular atrial fibrillation. Am J Cardiol . 2011;107(6):912-916.
  36. Tanaka H, Sonoda M, Kashima K, et al. Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation. Circ J . 2009;73(5):846-850.
  37. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation . 2003;107(1):87-92.
  38. Tomura S, Nakamura Y, Doi M, et al. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. Am J Kid Dis . 1996;27(6):848-854.